Processing equipment

Acasti and CordenPharma look to continuous production for omega-3 drug

06-Jun-2017 By Dan Stanton

Continuous manufacturing equipment installed at a CordenPharma French facility has reduced cycle time and cost of making a hypertriglyceridemia drug, says Acasti Pharma.

Q&A with the 'Medical Futurist'

'If only everyone's supply chain was as regulated and secure as pharma’s'

05-Jun-2017 By Dan Stanton

3D printing, augmented reality and deep learning algorithms will shape the future of the pharmaceutical supply chain says Dr Bertalan Mesko, the Medical Futurist.

Russian partnerships: Pfizer and NovaMedica break ground on aseptic plant

01-Jun-2017 By Dan Stanton

Pfizer and NovaMedica have broken ground on a manufacturing facility in Kaluga set to supply the Russian market with sterile injectable drugs.

Cambrex continues to up capacity with more than $200m invested in 5 years

31-May-2017 By Melissa Fassbender

Cambrex Corporation has increased new capacity at its Sweden-based cGMP as the manufacturer focuses on market demand and customer need, says VP.

Visible particulates and leaking bags land B Braun Cali plant with FDA warning

31-May-2017 By Dan Stanton

The US FDA has slammed B. Braun Medical for repeatedly failing to thoroughly investigate quality concerns at a drugmaking facility in California.

Looking to the long-term: Serialisation regulations here to stay, Tracelink

23-May-2017 By Dan Stanton

Pharma and CMOs must start addressing their serialization needs ahead of 2019’s EU Falsified Medicines Directive, says Tracelink which is bringing its supply chain event NEXUS to Barcelona next month.

France's ANSM raises GMP concerns at Brazilian aseptic plant

17-May-2017 By Dan Stanton

Nova DFL’s dental adrenaline product has been denied marketing authorisation after French regulators raised seven critical deficiencies at its facility in Brazil.

Thermo Fisher Scientific Inc to buy Patheon NV for $7.2bn

15-May-2017 By Gareth Macdonald

Thermo Fisher Scientific Inc has announced its intention to buy Patheon NV in a deal agreed by both firms’ boards.

How Thermo Fisher buying Patheon could simplify pharma supply chains

15-May-2017 By Dan Stanton

Thermo Fisher Scientific is set to buy contract manufacturer Patheon, but what would this mean for the life science tech firm?

Trump needs to back bioscience to boost US drug making say experts

11-May-2017 By Gareth Macdonald

President Donald Trump should foster biotech investment if he wants more US-made pharmaceuticals say experts who argue that cutting regulations to attract small molecule drug manufacturers will only have a limited effect.

Unused €107m pilot plant in France to be demolished, says Sanofi

11-May-2017 By Dan Stanton

Sanofi says it will demolish a pilot plant in Montpellier that has been left idle since its completion in 2011, citing its evolving biologics-focused portfolio.

Patheon spends $26m to up capacity for liquid and freeze-dried drugs

09-May-2017 By Gareth Macdonald

Patheon NV has completed a $26m-expansion of its Greenville, North Carolina manufacturing site at which it will make lyophilised pharmaceuticals.

PE backer stumps up $12.3m to help Teewinot grow cannabinoid business

03-May-2017 By Flora Southey

Teewinot Life Sciences has closed a $12.3m (€11.2m) deal with investment manager Tuatara Capital.

Romaco's PE owner sells majority of stake to China-based Truking

02-May-2017 By Staff reporter

Romaco GmbH owner DBAG has sold most of its stake in the processing technology firm to Truking Group.

AMRI says it is well placed to win more NCATS contracts

AMRI gets 5-year NIH API manufacturing and process dev contract

02-May-2017 By Gareth Macdonald

AMRI has been hired by the NIH to provide synthesis and manufacturing services for APIs being developed by the National Center for Advancing Translational Sciences (NCATS) division of preclinical innovation.

Catalent to increase spray-drying capacity for APIs at Pharmatek

27-Apr-2017 By Gareth Macdonald

Catalent Pharma Solutions has said it will increase spray drying capacity at a plant owned by recent acquisition Pharmatek Laboratories.

MPP to make hep C drug affordable for low and middle income countries

26-Apr-2017 By Flora Southey

Pharco Pharmaceuticals has granted a license to make, sell and export the hepatitis C drug ravidasvir (RAV) to Medicines Patent Pool (MPP).

update

US FDA warns Lonza about Walkersville site

25-Apr-2017 By Gareth Macdonald

The US FDA has warned Lonza about operations at its facility in Walkersville, Maryland, raising concerns about validation and aseptic process simulations.

1st Stem Cell Community day in Germany

For stem cells 'the process is the product,' says Pluristem

19-Apr-2017 By Dan Stanton

Manufacturing tweaks have severe effects on the quality and yield of stem cells, says Pluristem which has successfully scaled-up production through a decade of process development evolution.

Pork firm Smithfield sets up organ supply unit for regenerative meds sector

13-Apr-2017 By Staff reporter

Smithfield Foods Inc. has tasked a new bioscience unit with turning byproducts from its pork business into supplies for regenerative meds and drug firms.

Fresenius Kabi in talks to buy Akorn

10-Apr-2017 By Gareth Macdonald

Akorn Inc is in takeover talks with German injectable drug specialist Fresenius SE & Co. KGaA.

Sumitomo Dainippon buys cell therapy processing tech from Hitachi

10-Apr-2017 By Gareth Macdonald

Sumitomo Dainippon Pharma Co Ltd has ordered cell culture technologies from Hitachi as part of its effort to develop a treatment for Parkinson’s disease.

Permira to buy Lyophilization Services of New England

28-Mar-2017 By Gareth Macdonald

Private equity fund Permira has announced its intention to buy freeze drying firm Lyophilization Services of New England Inc (LSNE)

Misbranded epilepsy drug API lands FDA warning for Chinese ingredient maker

15-Mar-2017 By Dan Stanton

The US FDA has slammed China’s Lumis Global Pharmaceuticals for problems documenting and labelling active pharmaceutical ingredients.

DSM Sinochem licenses enzymatic antibiotic production tech to Sandoz; sues Weiqida

15-Mar-2017 By Gareth Macdonald

DSM Sinochem Pharmaceuticals has licensed enzyme-based antibiotic production IP to Sandoz and accused Sinopharm Weiqida Pharmaceutical of patent infringement.

Apotex expanding US footprint with $184m investment

09-Mar-2017 By Staff Reporter

Generics maker Apotex will construct a manufacturing and packaging facility as part of a $184m US expansion.

Re-inspection lands Dr Reddy’s Form 483 with 13 observations at Duvvada plant

09-Mar-2017 By Dan Stanton

Dr Reddy’s Laboratories says it is addressing the observations at its Duvvada plant which was hit with a warning letter in 2015.

Opioid API firm Noramco moves into cannabinoids

08-Mar-2017 By Gareth Macdonald

Noramco has added cannabinoids to its portfolio of opioid APIs.

Merck KGaA's Allergopharma opens production facility

06-Mar-2017 By Gareth Macdonald

Merck KGaA has opened a €42m production facility in Reinbek near Hamburg, Germany.

Allergan's €42m investment boosts Irish manufacturing and jobs

02-Mar-2017 By Dan Stanton

Allergan has committed €42m ($44m) to increase capacity and capabilities at two manufacturing facilities in Ireland.

GSK seeks advice on planned Scottish respiratory API plant

28-Feb-2017 By Gareth Macdonald

GSK has asked Angus Council for advice as it prepares to submit a planning application for an API plant it intends to build at its site in Montrose, Scotland.

Looking to gain a foothold in Ireland? MSD puts shuttered site up for sale

28-Feb-2017 By Dan Stanton

Merck & Co. has put an Irish small molecule plant up for sale after ceasing production late last year.

GSK: Costa Rican Panadol plant closure will eliminate 60 jobs

27-Feb-2017 By Dan Stanton

GSK says the closing of its Costa Rica manufacturing facility is necessary to ensure the long-term viability of its consumer healthcare business.

Momenta says Pfizer will fix plant but reiterates that Glatopa 40mg ANDA delay likely

22-Feb-2017 By Gareth Macdonald

Momenta Pharmaceuticals has reiterated its belief that problems at a US Pfizer plant mean the FDA is unlikely to reach a decision on its 40mg version of Teva’s Copaxone before April.

Symbiosis opens US sales office citing demand from resurgent biotechs

13-Feb-2017 By Gareth Macdonald

Symbiosis has opened an office in Boston, Massachusetts citing growing demand for vial filling services for highly potent APIs and large molecule injectable formulations.

Atlas to invest in extra capacity at STI test manufacturing partner Bespak

13-Feb-2017 By Dani Bancroft

Atlas Genetics has said it will expand manufacturing capacity for cartridge-based STI tests at a UK facility owned by drug delivery technology firm Bespak Europe ltd.